Executive Summary
A remarkable cluster of 33 8-K filings on January 22, 2026, reveals widespread corporate distress signals among predominantly small-cap US firms, dominated by entries into material definitive agreements (Item 1.01 in ~80% of cases), unregistered equity sales (Item 3.02), new financial obligations (Item 2.03), and governance amendments (Items 3.03/5.03). This synchronized activity points to a liquidity crunch driving emergency financings, dilutions, and restructurings, with neutral sentiment masking elevated medium-high risks of dilution, debt burdens, and delistings. Portfolio managers should reduce micro-cap exposure amid potential contagion, while monitoring for alpha in distressed asset turnarounds.
Tracking the trend? Catch up on the prior US Corporate Distress Financial Stress SEC Filings digest from January 20, 2026.
Investment Signals(4)
- Pluri Inc.↓(BEARISH)▲
Notice of delisting or failure to satisfy listing standards, severely threatening liquidity and valuation
- Avalon GloboCare Corp.↓(BEARISH)▲
Termination of material definitive agreement erodes strategic partnerships and raises operational risks
- ORAGENICS INC↓(BULLISH)▲
Entry into material definitive agreement signals potential strategic partnership or acquisition
- American Rebel Holdings Inc.↓(BULLISH)▲
Multi-item filing including strategic agreement and Reg FD disclosure hints at turnaround efforts
Risk Flags(4)
High materiality (10/10) notice of delisting or listing failure, imminent liquidity crisis risk
- Multiple Firms/Dilution (e.g., Anteris Technologies, AMERICAN REBEL, SurgePays)▼
Unregistered equity sales in 8+ filings pose widespread shareholder dilution
- Multiple Firms/Debt Obligations (e.g., Installed Building Products, Worthington Steel)▼
Item 2.03 creations of financial obligations signal rising leverage and balance sheet stress
Bearish termination of key agreement (Item 1.02) with high risk level
Opportunities(4)
Potential strategic partnership or financing stabilizing operations in biotech space
Multi-item filing with Reg FD may disclose growth initiatives for alpha in biotech recovery
Equity sales paired with material agreement could fund robotics turnaround
Item 1.01 agreement in biotech offers partnership upside if exhibits reveal positive terms
Sector Themes(3)
- Small-Cap Liquidity Crunch◆
33 same-day filings dominated by Item 1.01 financings and Item 3.02 dilutions indicate systemic cash shortages in micro-caps, pressuring valuations
- Biotech/Health Distress Wave◆
Cluster in firms like Anteris, Neuronetics, Terns Pharma, Tharimmune, BioAge, Janux, Shattuck signals sector funding drought, ripe for M&A
- Governance Restructuring Surge◆
Frequent Items 3.03/5.03 (e.g., 22nd Century, Mission Produce) suggest reverse splits or rights changes as distress precursors
Watch List(4)
Monitor progression of listing failure and potential OTC transfer or bankruptcy
Track impacts of termination and any follow-on financing needs
Complex termination + new obligations (Items 1.02, 2.03) could signal broader construction sector woes
Item 2.03 debt creation amid material agreement warrants leverage ratio checks
Filing Analyses(33)
22-01-2026
Strive, Inc. filed a Form 8-K on 2026-01-22 (AccNo: 0001140361-26-002005, Size: 574 KB), reporting Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, events, or exhibits provided. Sector not specified.
22-01-2026
Anteris Technologies Global Corp. filed an 8-K on January 22, 2026 (AccNo: 0001140361-26-001938, Size: 1 MB), reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits under Item 9.01. No details on the agreement, transaction value, parties involved, or financial impacts are provided in the summary. Sector not specified.
22-01-2026
AMERICAN REBEL HOLDINGS INC filed a Form 8-K on January 22, 2026 (AccNo: 0001493152-26-003143, Size: 6 MB), reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation), 3.02 (Unregistered Sales of Equity Securities), 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific transaction details, dollar values, share counts, or other numerical data are disclosed in the provided filing summary. This is a multi-item mandatory filing from us_sec source.
22-01-2026
Global Business Travel Group, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001104659-26-005456, Size: 2 MB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, counterparties, or financial impacts are disclosed in the provided filing summary. Sector not specified.
22-01-2026
Neuronetics, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001193125-26-018674, Size: 195 KB), reporting under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 discloses Financial Statements and Exhibits. No details on the agreement's nature, counterparties, value, or financial impacts are provided.
22-01-2026
22nd Century Group, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001493152-26-003185), reporting under Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and Item 9.01 (Financial Statements and Exhibits). No specific details, transaction values, named entities, or quantitative data are disclosed in the provided filing summary. This is a multi-item mandatory filing indicating governance changes.
22-01-2026
SunCoke Energy, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001514705-26-000005, Size: 222 KB), reporting entry into a material definitive agreement (Item 1.01), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item filing with mandatory disclosures for Items 1.01 and 7.01. No specific details on the agreement, transaction value, financial impacts, or other quantitative data are disclosed in the provided filing summary.
22-01-2026
Avalon GloboCare Corp. filed a Form 8-K on January 22, 2026 (AccNo: 0001213900-26-006488, Size: 252 KB), disclosing under Item 1.02 the termination of a material definitive agreement, under Item 7.01 a Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item material event filing from the US SEC with no specific transaction details, dollar values, or financial metrics provided. Sector is not specified.
22-01-2026
SurgePays, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001493152-26-003208, Size: 799 KB), reporting under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, Item 8.01 other events, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific transaction details, dollar values, share counts, or financial metrics disclosed in the provided information. Sector is not specified.
22-01-2026
Ameritek Ventures, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001376474-26-000062, Size: 577 KB) reporting Items 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the events, transactions, dollar values, or financial impacts disclosed in the provided summary. Sector not specified.
22-01-2026
Unnamed company filed a Form 8-K on January 22, 2026 (AccNo: 0001929017-26-000004), reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item material event filing with no specific transaction details, dollar values, financial metrics, or named entities disclosed in the provided summary. Sector not specified.
22-01-2026
Terns Pharmaceuticals, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001193125-26-019426, size 143 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement. No details on the agreement's nature, parties, transaction value, or financial terms are disclosed in the provided information. Sector is not specified.
22-01-2026
An unnamed company filed a Form 8-K on January 22, 2026 (AccNo: 0001414475-26-000004, Size: 467 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item material event filing with event date January 22, 2026; sector not specified. No details on the agreement, disclosures, transaction value, or financial impacts are provided.
22-01-2026
Western Midstream Partners, LP filed a Form 8-K on January 22, 2026 (AccNo: 0001423902-26-000004, Size: 479 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, transaction value, or financial impacts disclosed in the provided summary. Sector not specified.
22-01-2026
Mission Produce, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001193125-26-019420, Size: 552 KB), reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, values, or financial impacts disclosed in the provided information. Sector is not specified.
22-01-2026
Oragenics Inc filed a Form 8-K on January 22, 2026 (AccNo: 0001493152-26-003237, size 232 KB), reporting entry into a Material Definitive Agreement under Item 1.01. Item 9.01 discloses Financial Statements and Exhibits. No details on the agreement, transaction value, parties, or financial impacts are provided in the filing summary.
22-01-2026
CDT Equity Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001493152-26-003244, Size: 986 KB), reporting under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific transaction details, dollar values, share counts, or financial impacts disclosed. All quantitative and descriptive data beyond the items reported is NOT_DISCLOSED.
22-01-2026
Tharimmune, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001493152-26-003242, Size: 702 KB) reporting Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, events, or exhibits provided in the summary. Sector not specified.
22-01-2026
The company filed a Form 8-K on January 22, 2026 (AccNo: 0001611547-26-000004, Size: 261 KB), reporting entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item mandatory filing classified as a Material Event, but no specific details on the transaction, parties, value, or impacts are disclosed in the provided filing summary. All quantitative data, named entities, and further specifics are NOT_DISCLOSED.
22-01-2026
Company filed 8-K on 2026-01-22 (AccNo: 0001193125-26-019487, Size: 214 KB) reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement). Item 9.01 indicates Financial Statements and Exhibits are included. No specific transaction details, parties, amounts, or financial metrics disclosed.
22-01-2026
Light & Wonder, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001104659-26-005821, Size: 1 MB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No details on the agreement's parties, terms, value, or financial impact are disclosed in the provided filing summary. Sector is not specified.
22-01-2026
BioAge Labs, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001193125-26-019536, size 863 KB), reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, parties involved, or financial impacts are disclosed in the provided summary. This is a multi-item mandatory filing triggered by material events.
22-01-2026
ALTA EQUIPMENT GROUP INC. filed an 8-K on 2026-01-22 (AccNo: 0001193125-26-019511, size 475 KB) disclosing entry into a Material Definitive Agreement under Item 1.01 and Financial Statements and Exhibits under Item 9.01. No details on the agreement, transaction value, counterparties, financial impacts, or strategic rationale are provided in the summary. Sector not specified.
22-01-2026
Installed Building Products, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001628280-26-003102, Size: 136 MB), reporting entry into a material definitive agreement (Item 1.01), termination of a material definitive agreement (Item 1.02), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item filing signaling significant contractual and financial changes, but all specific details including transaction values, counterparties, and impacts are NOT_DISCLOSED. No quantitative financial metrics or named entities beyond the filer are provided.
22-01-2026
Janux Therapeutics, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001193125-26-019520, Size: 223 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). Sector not specified. No specific details on the agreement, transaction value, or other quantitative data provided.
22-01-2026
Worthington Steel, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001193125-26-019521, Size: 850 KB), reporting entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item mandatory filing, but specific transaction details, dollar values, counterparties, and impacts are NOT_DISCLOSED. Sector is not specified.
22-01-2026
Sachem Capital Corp. filed a Form 8-K on January 22, 2026 (AccNo: 0001682220-26-000004, Size: 318 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing disclosing a material agreement with exhibits attached. No specific details on the agreement, transaction value, counterparties, or financial impacts are provided in the available summary.
22-01-2026
Pluri Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001213900-26-006685, Size: 197 KB) reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No additional details on the specific reason for delisting, financial impacts, transaction values, or sector are disclosed. This represents a material regulatory event potentially affecting stock liquidity and trading.
22-01-2026
EKSO BIONICS HOLDINGS, INC. filed a Form 8-K on January 22, 2026 (AccNo: 0001437749-26-001774), disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03), and financial statements and exhibits (Item 9.01). No specific transaction details, dollar values, share counts, or other quantitative data are provided in the summary. Sector is not specified.
22-01-2026
MSP Recovery, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001193125-26-019666, Size: 272 KB), disclosing under Item 1.01 entry into a Material Definitive Agreement, under Item 2.03 creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement, and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory filing with no specific transaction details, dollar values, parties, or terms provided in the summary. Sector not specified.
22-01-2026
Shattuck Labs, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001193125-26-019682, Size: 469 KB), reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. Sector not specified. No further details on the agreement, transaction value, or exhibits provided.
22-01-2026
Crypto Co filed a Form 8-K on January 22, 2026 (AccNo: 0001493152-26-003266, size 328 KB), reporting under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, sales, transaction values, counterparties, or financial impacts disclosed. Sector not specified; no scheduled events or quantitative metrics mentioned.
22-01-2026
TALOS ENERGY INC. filed a Form 8-K on 2026-01-22 (AccNo: 0001193125-26-019703, Size: 2 MB) reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on the core event, transaction value, parties involved, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This appears to be a multi-item mandatory filing related to a significant agreement and financial obligation.
Get daily alerts with 4 investment signals, 4 risk alerts, 4 opportunities and full AI analysis of all 33 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC